FEMASYS INC
FEMY · XNASCIK 1339005fmd_0C9A0FQVXRW9FV0DT3K2DFHCQMManufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard
Coverage: Jan 01, 2020 to Jun 30, 2026, 25 periods
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Total revenues | 1 | 1 | 1 | 1 | 2 | 2 |
| Cost of revenue | 0 | 0 | 0 | 0 | 1 | 1 |
| Gross profit | 1 | 1 | 1 | 1 | 1 | 1 |
| Research and development | 4 | 4 | 6 | 7 | 8 | 8 |
| Selling, general and administrative | 3 | 4 | 6 | 8 | 10 | 11 |
| Total operating expenses | 8 | 9 | 12 | 15 | 19 | 19 |
| Operating income | (7) | (8) | (12) | (15) | (18) | (18) |
| Interest expense | 0 | 0 | 0 | 0 | 2 | 2 |
| Interest and investment income | – | – | – | 0 | 1 | 0 |
| Other non-operating income (expense) | 0 | 1 | 0 | 0 | (1) | (1) |
| Income before taxes | (7) | (8) | (11) | (14) | (19) | (19) |
| Income tax expense | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income from continuing operations | (7) | (8) | (11) | (14) | (19) | (19) |
| Net income | (7) | (8) | (11) | (14) | (19) | (19) |
| Net income to common shareholders | (7) | (8) | (11) | (14) | (19) | (19) |